Anti-tumor necrosis factor (TNF) therapy was determined to be useful for controlling several recalcitrant uveitides (20, 21); IL-6 inhibitors also showed efficacy in refractory JIA-associated uveitis, Behcet’s uveitis and so on (22, 23). Here, TNF is linked to juvenile idiopathic arthritis.